Clinical trials of PGE1, PGI2 and mimetics in patients with peripheral vascular disease.
Sinzinger
H
H
Atherosclerosis Research Group, University of Vienna, Austria.
Virgolini
I
I
O'Grady
J
J
D000527:Alprostadil / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D011464:Epoprostenol / Q000627:therapeutic use / Q000031:analogs & derivatives; D006801:Humans; D016285:Iloprost; D011453:Prostaglandins / Q000627:therapeutic use*; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D014652:Vascular Diseases / Q000188:drug therapy*
D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; C039188:taprostene; D011464:Epoprostenol; D000527:Alprostadil; D016285:Iloprost